Hyaluronidase / trastuzumab User Reviews & Ratings
Brand names: Herceptin Hylecta
Hyaluronidase / trastuzumab has an average rating of 10.0 out of 10 from a total of 1 reviews on Drugs.com. 100% of reviewers reported a positive experience, while 0% reported a negative experience.
| Condition | Avg. Rating | Reviews | Compare |
|---|---|---|---|
| Breast Cancer | 1 reviews for Breast Cancer | 79 medications | |
| Add your review | |||
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about hyaluronidase / trastuzumab
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: HER2 inhibitors
- En español
Patient resources
- Hyaluronidase and trastuzumab drug information
- Trastuzumab and hyaluronidase-oysk (Advanced Reading)
Herceptin Hylecta (hyaluronidase / trastuzumab) for Breast Cancer "Switched to this form of Herceptin from a 30-minute infusion by port. I continue to get clean Pet Scans. Much shorter treatment time-the SQ injection only takes 6-10 minutes and there is no after-discomfort. Much less stress to be in and out of Infusion in less than one hour."